Following its recent clearance by FDA for marketing in the United States, the SignosRT bladder scanner is now available in Europe and the United Kingdom as well, according to its Australian-based manufacturer, Signostics Limited. The roll-out includes the company’s recently developed tablet-based version of the scanner. Both products were recently displayed at the European Association of Urology (EAU) conference in Madrid.
The scanner is designed to be simple to use in order to non-invasively image the bladder, giving automatic bladder measurements. The company says the lightweight device is portable and priced to be affordable, delivering reliable measurements that help to prevent unnecessary catheterization. The new tablet version is designed for pole-mounting in hospital wards and similar applications.
“Catheterization of patients with suspected urinary retention is a significant cause of urinary tract infections, affecting about 1.7% of hospital patients and increasing the length of hospital stays,” said Steven Haken, Signostics vice president of business development for Europe, Middle East, and Africa. “Research shows using ultrasound to accurately measure bladder volume before catheterization can reduce urinary tract infections by up to 50%, which is significant for both health providers and patients.”
According to Signostics, the bladder scanner has applications across a number of medical sectors including urology, aged care, home nursing, midwifery, and palliative care. For more information about the device, visit the Signostics website.